The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
LETYBO (CROMA Australia Pty Ltd)
Product name
LETYBO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
222 (255 working days)
Active ingredients
letibotulinumtoxinA
Registration type
NCE/NBE
Indication
LETYBO is indicated for the temporary improvement in the appearance of moderate to severe glabellar frown lines in adults.